Aims/hypothesis We conducted genome-wide association studies (GWASs) 
IL34) and six intergenic regions. Among these was a missense polymorphism (rs10462020; Gly639Val) in the clock gene PER3, a system recently implicated in diabetes. We also report a second signal (minimum p value 1.52× 10 −6 ) within PTPRD, independent of the previously implicated SNP, in a population of Han Chinese. Top meta-analysis signals included known regions HNF1A and KCNQ1. Annotation of top association signals in both studies revealed a marked excess of trans-acting eQTL in both adipose and muscle tissues.
Conclusions/Interpretation
In the largest study of type 2 diabetes in Mexican populations to date, we identified modest associations of novel and previously reported SNPs. In addition, in our top signals we report significant excess of SNPs that predict transcript levels in muscle and adipose tissues.
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Introduction
Genome-wide association studies (GWASs) of type 2 diabetes in large samples of recent European descent have identified a number of susceptibility loci; it is widely accepted that, to further understand the genetic aetiology of type 2 diabetes, it will be necessary to replicate these findings and identify new loci using other populations. Mexican-Americans have disproportionately high rates of type 2 diabetes. In order to identify genetic variants contributing to type 2 diabetes susceptibility in MexicanAmericans we conducted both binary trait and ordinal GWA on 1618 individuals from Starr County with diabetes (cases), impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), or normal fasting glucose and glucose tolerance (controls), using nearly 2 million directly interrogated and imputed markers. These analyses were combined in meta-analyses with the results from GWASs of admixed Mexicans from Mexico City [1] . This sample is described in detail in the companion paper. These cohorts comprise the largest type 2 diabetes analysis in Mexican and Mexican-American samples to date. In addition, we followed our association and meta-analyses by annotating SNPs with expression quantitative trait loci (eQTL) information from lymphoblastoid cell lines (LCLs) as well as adipose and muscle tissues, to characterise possible functional roles for SNPs associated with type 2 diabetes.
Methods
Study population and phenotype assessment Using the 1979 National Diabetes Data Group criteria [2] , cases (n=990) and controls (n=990) were selected from genetic and epidemiological resources developed in the MexicanAmerican population in Starr County, TX, USA (these also meet definitions set out in the 1997 ADA criteria [3] ).
Of the 931 successfully genotyped case samples, we selected 837 unrelated individuals for our analyses. A representative type 2 diabetes control sample was selected from a systematic survey of the primary population centres of Starr County conducted from 2002 to 2006. Blocks were randomly selected within primary population centres in Starr County, and all individuals in each household on selected blocks were enumerated. A random individual aged 20 years and above with no history of diabetes was selected from each household for a physical evaluation including an oral glucose tolerance test with a 75 g glucose load. From 1,345 oral glucose tolerance tests, 350 individuals were classified as having diabetes based on their fasting or 2 h post-load glucose, and were excluded from consideration as controls.
From the remaining 995 individuals, 990 were selected for genotyping, and after genotype quality control and pruning related samples, the control sample included 781 unrelated Starr County residents. Of these, 345 individuals had IGT (defined as a blood glucose level of 7.8-11.0 mmol/l after a 2 h oral glucose tolerance test) or impaired fasting glucose (defined as fasting blood glucose level of 5.6-6.9 mmol/l after overnight fast) and were included in the IGT/IFG category as an intermediate phenotype in the ordinal analysis. Table 1 summarises phenotypes measured in the case, IGT/IFG and control groups.
Genotyping and quality control Genomic DNA was isolated from whole blood of 1,980 unique individuals from Starr County, and quantified by picogreen. The Affymetrix Genome-Wide SNP Array 6.0 assay was performed according to manufacturer protocols (Affymetrix, Santa Clara, CA, USA) at the Center for Inherited Disease Research. Case, IGT/ IFG, and control groups were randomised to plates. Genotypes were called for 1,890 samples passing quality control (QC) using both the Affymetrix supported Birdseed v2 [4] calling algorithm as well as the corrected robust linear model with maximum likelihood classification (CRLMM) [5] and only calls in complete agreement between the two algorithms were used in analyses.
No samples uniformly failed contrast QC (CQC) and skewness QC (SQC) [6] in the Affymetrix enzyme-specific subsets as well as the full set of enzyme-specific SNPs. Plate effects were examined [6] [7] , SNP and individual level call rates were calculated as well as sex incompatibilities (one mismatch identified and removed using markers on the X and Y chromosomes). All individuals passed per sample missingness of <0.1 and 7124 SNPs were removed as a result of missingness >0.1. Identical-by-descent (IBD) estimations were calculated in PLINK and an 'unrelated' cohort of 1,618 samples was created with a proportion of pairwise sharing IBD less than 0.28, weighting inclusion of cases and higher call rate. Individual and plate level heterozygosity was estimated in PLINK and no outliers observed. SNPs with minor allele frequency (MAF) <0.01 were removed. Departures from Hardy-Weinberg equilibrium were calculated and flagged in the full sample, cases, and controls.
Major ancestry group components for the unrelated admixed sample in a SNP set pruned of local and longdistance linkage disequilibrium (LD) were calculated in EIGENSTRAT [8] (Fig. 1a) ; however, neither of the first two principal components were found to be significantly correlated with type 2 diabetes (mean regression p values were 0.18, 0.39, with Pearson correlation coefficients between covariate and phenotype of 0.005 and 0.021, respectively), similar to our previous findings [9] . Although we did not see significant correlation of type 2 diabetes and European admixture in the Starr County sample, strong correlation was observed in the Mexico City study (Fig. 1b) . To prevent excessive false positive rates, all analyses in the Mexico City sample controlled for the distribution along the primary axis of variation. For additional details of covariates in this sample please refer to the companion paper [10] .
Imputation We performed imputation in MACH 1.0 [11, 12] from consensus call genotypes with MAF >0.01 in 1,618 Starr County Mexican-Americans to the full panel of CEU (Centre d'Etude du Polymorphisme [Utah residents with northern and western European ancestry]), YRI (Yoruba in Ibadan, Nigeria), and JPT (Japanese in Tokyo, Japan) + CHB (Han Chinese in Beijing, China) HapMap2 phased polymorphic SNPs from release 22 [13] . In total 137,532 SNPs with an estimate of the squared correlation between imputed and true genotypes, r 2 ≤0.7 (as estimated by MACH) were removed. An additional 2,616 SNPs with MAF <0.01 were removed, resulting in 1,829,586 genotyped or imputed markers for analyses.
Type 2 diabetes association analyses We used SNPtest [14] to calculate the Armitage trend test using covariates and the Meta-analysis Type 2 diabetes association results from SNPtest in Mexicans from Mexico City were combined with results from the associations in the Starr County sample using SNPtest's companion program META [16] . We performed principal component analysis (PCA) in EIGENSTRAT on a local and long-distance LD-pruned SNP set in the Mexico City sample as well as together with parental populations, to check homogeneity between the samples (Fig. 1b, c We generated 1,000 random SNP sets, each of the same size (n=722) as the original list of LD-pruned top signals (r 2 >0.30), containing variants matched on MAF distribution, sampled without replacement from the set of typed SNPs on the Illumina 1M platform; MAF matching was done by drawing from the platform SNPs, which had been grouped into discrete MAF bins, each spanning 5% of the allele frequency spectrum. These simulations (n = 1,000) yield an empirical p value, calculated as the proportion of simulations in which the number of eQTLs exceeds the observed number, Q, in the list of top type 2 diabetes signals.
Results
Association and meta-analyses All analyses were performed using the combined age/dxage measurement and sex as covariates and association tests were conducted with and without correcting for BMI. We estimated the inflation factors (the ratio of the trimmed means of the observed and expected values), λ age/dxage+sex =1.034 and λ age/dxage+sex+BMI =1.026 in the case-control analysis and 1.038 and 1.023 (respectively) in the three-category ordered logistic regression. The Manhattan and quantile-quantile (QQ) plots summarising results from the ordinal logistic regression without BMI as a covariate are presented in Fig. 2a , b (others are in ESM  Figs 1-3) . Forty-nine high quality SNPs, with an uncorrected p value <1 × 10 −5 in at least one analysis, fell within 14 genomic regions, and are listed, with p values from the analysis, in Table 2 and depicted in Fig. 2a (p values for these markers in each analysis can be found in ESM Table 1) . These top signals fall within eight genic regions: PER3, PARD3B, EPHA4, TOMM7, PTPRD, HNT (also known as RREB1), LOC729993 (also known as SHISA9), IL34, and six intergenic regions. In general, the SNPs within these genic and intergenic regions represent single blocks of LD (r 2 > 0.7). Aside from the SNPs in PARD3B and EPHA4, which have MAF of about 0.05, these signals are driven by common variation (MAF > 0.1) ( [9] , were examined in detail (ESM Table 2 ). We also examined our results for variation within CAPN10, previously reported as a type 2 diabetes gene in Mexican-Americans, but key SNPs in the associated CAPN10 haplotypes were neither directly interrogated nor imputed.
The top meta-analysis signals fell within and near the genes CSMD1 and HNF1A; additional signals implicated LSAMP, FGF12, RP11-354K1.1, KCNQ1, ANK2, NIPAL2, RP11-74C3.1, CIT, C22orf30 (also known as PRR14L), EPHB2, MCPH1 and DEPDC5. Follow-up meta-analysis of top signals from the combined Mexican/Mexican-American studies with the recent DIAGRAM+ dataset identified genome-wide significant signals (p value <5×10 −8 ) in or near susceptibility genes HNF1A and CDKN2A/CDKN2B, and suggestive evidence for IGF2BP2, KCNQ1 and the previously unreported C14orf70. For additional details of the meta-analyses of these samples and follow-up of top signals in DIAGRAM+, please refer to the companion paper.
In addition to physical proximity, we considered the roles that SNPs in the top signals play in transcript prediction. for all meta-analysed SNPs.
Annotation of LD-pruned top signals (p value <1×10
Chr, chromosome; Freq, frequency; Pos, position; UTR, untranslated region of the enrichment in muscle and adipose tissue is driven by trans-acting eQTLs; only three of the eQTLs observed in muscle, and eight in adipose tissue, were cis-acting. In addition, we replicated the observed enrichment in muscle and adipose tissues in the top signals (defined as described above) from the analysis in the Mexico City sample (Fig. 4a, b) . A number of SNPs showing association for type 2 diabetes in our studies predicted gene expression across multiple tissues; 14 SNPs predict expression in all three tissues tested (ESM Fig. 5 ).
Discussion
As studies of genetic association in type 2 diabetes are pursued in non-European populations, it is important to recognise that, in populations with markedly increased disease rates, there may be room to improve on the casecontrol study design. In this case, we favour an approach that uses more information and recognises the staging of the disease, enabling us to recover a substantial number of individuals. In general, the results of the ordinal and binary analyses are very similar, but including the intermediate class allows us to include more of the individuals in the sample, and should, therefore, provide a more complete picture of the association of genetic variation with the spectrum of phenotypes related to type 2 diabetes. Among the top signals in the ordinal analysis is a functional missense polymorphism in the clock gene PER3. Substantial research has implicated circadian clock function in metabolic diseases, coronary function and obesity [23] [24] [25] , but this signal is not replicated in the Mexico City sample (p value ∼0.78).
Another top signal from the Starr County sample, as well as in the meta-analysis with Mexico City, implicates a previously reported type 2 diabetes risk gene PTPRD. PTPRD, protein tyrosine phosphatase receptor type delta gene [26] , was recently identified by GWAS in Han Chinese populations [26] . Although the SNPs are both intronic, our result is 1.6 Mb downstream and represents an independent signal from within the gene (the SNPs are in linkage equilibrium in HapMap CHB + JPT as well as CEU samples). The role of PTPRD in type 2 diabetes is not yet understood; however, when ablated in mice, genes in this subfamily induce defects in glucose homeostasis and insulin sensitivity [27, 28] .
There is little literature suggesting roles for IL34, TOMM7, HNT or PARD3B, nor the intergenic regions, in diabetes; however, in HapMap Europeans, LD extends from several of these top regions to include candidate genes for type 2 diabetes. For example, two intergenic SNPs on chromosome 12 are in high LD with PRMT8 (r 2 =0.764), a gene known to influence lipid levels [29] . Yet, LD with a type 2 diabetes-related gene alone is not sufficient evidence of a SNP's functional role. To assess functional consequences of associated variants, we explored our findings in the context of gene regulation.
Previous studies have identified enrichment of eQTLs in trait associated SNPs [30] . A recent study into the functional role of type 2 diabetes associated SNPs found an excess of eQTLs among signals from the Wellcome Trust Case Control Consortium and the Diabetes Genetics Initiative in muscle and adipose [31, 32] . The enrichment in these cases was driven almost exclusively by trans-acting eQTLs. This enrichment was robust to thresholds of eQTL p value (1 × 10 −6 was also considered and a similar level of enrichment is still observed) and threshold of significance of type 2 diabetes association (top 1,000 and top 10,000 signals were analysed and enrichment was seen in both). We find similar enrichment in both the Starr County and Mexico City datasets. The lack of enrichment of eQTLs in LCLs, despite significant enrichment of eQTLs from muscle and adipose tissue, is likely to be attributable to the fact that LCLs as a cell type are not as relevant as muscle and adipose tissue to type 2 diabetes risk, and only a proportion of eQTLs are shared across tissues [31, 32] . The number of SNPs predicting transcript level in both muscle and adipose tissue is markedly higher (178) than those overlapping LCLs (33), suggesting concordance of regulatory action in muscle and adipose tissues in a large proportion of top type 2 diabetes associated SNPs in our study. Previous studies of eQTLs in LCLs in top type 1 diabetes associated loci have found significant enrichment [30] , suggesting that lymphoblasts are a relevant tissue for type 1 diabetes; this is reassuring given the role of autoimmunity in the disease. Of the 53 previously reported SNPs considered (drawn from the NHGRI catalogue, DIAGRAM+, and Hayes et al. [9] , and interrogated or represented by proxy SNP in the Starr County analyses) we identified seven markers with p value <0.05 and odds ratios in the same direction. These markers are in or near IGF2BP2, WFS1, JAZF1, OR13D1-OR13D3P, KCNQ1, VPS33B, and EPB41L3-LOC645355. An additional 20 SNPs do not reach marginal significance in our dataset, but do show odds ratios in the same direction. Seventeen SNPs have previously reported confidence intervals for the odds ratios which overlap those observed in the Starr County dataset (all data shown in ESM Table 2 ).
As in all GWASs of type 2 diabetes published to date, we lack power to detect the kinds of small effect we now know are likely to contribute to disease risk (see ESM  Fig. 6 ). However, the absence of support for a number of established type 2 diabetes genes is notable in this dataset. Of particular interest is the lack of association of SNPs within TCF7L2, the gene with the strongest associations with type 2 diabetes observed in Europeans. While the allele frequency of the variant most strongly associated in Europeans is lower in Asian populations, estimates of the odds ratios were quite similar. In contrast, the frequency of the risk allele is similar in Mexican-Americans and Europeans, but the odds ratios are lower in both the MexicanAmerican and Mexico City datasets; in a fixed effects metaanalysis of SNP rs7903146 in our data and that of Voight et al. [22] , the heterogeneity p value is 0.05. Our confidence intervals for rs7903146 also overlap, but just barely, according to DIAGRAM estimates.
The winner's curse, the tendency of a biased overestimate of effect in the first study to report an association and be successfully published, may explain the somewhat higher overestimates of effect in the top signals in the Starr County and Mexico City studies [33] . In addition, ascertainment can contribute to these effects. For example, in Starr County, patients from families with two or more affected members were specifically targeted for the GWAS, which improves power, but leads to estimates of effect size that are larger than would be estimated in an unselected case series. In general, however, lack of replication is likely to be due to the fact that all studies of type 2 diabetes to date are under-powered to detect small effects, and therefore only detect association signals from some (probably different) subset of the contributing variants.
To identify, confirm, and characterise additional genetic risk factors for type 2 diabetes it is likely that we will need to continue studies in non-European populations, to explore new study designs and methods of analysis in high-risk groups, and to enhance GWAS with eQTL and other functional studies.
